GF FUND MANAGEMENT CO. LTD. Q3 2025 Filing

Filed November 7, 2025

Portfolio Value

$5.5B

Holdings

631

Report Date

Q3 2025

Filing Type

13F-HR

All Holdings (631 positions)

#StockSharesValue% PortfolioType
601
ALLOAllogene Therapeutics Inc
4,774$5.9M0.11%
602
FHTXFoghorn Therapeutics Inc
1,192$5.8M0.11%
603
RNACCartesian Therapeutics Inc
549$5.6M0.10%
604
VYGRVoyager Therapeutics Inc
1,193$5.6M0.10%
605
NGNENeurogene Inc
316$5.5M0.10%
606
KYTXKyverna Therapeutics Inc
898$5.4M0.10%
607
ENTAEnanta Pharmaceuticals Inc
448$5.4M0.10%
608
AVIRAtea Pharmaceuticals Inc
1,754$5.1M0.09%
609
SLNSilence Therapeutics PLC
978$5.1M0.09%
610
CDXSCodexis Inc
1,942$4.7M0.09%
611
TRDAEntrada Therapeutics Inc
807$4.7M0.08%
612
IRWDIronwood Pharmaceuticals Inc
3,387$4.4M0.08%
613
OABIOmniAb Inc
2,587$4.1M0.08%
614
MXCTGBXMaxCyte Inc
2,256$3.6M0.06%
615
CCCCC4 Therapeutics Inc
1,463$3.2M0.06%
616
TVGNTevogen Bio Holdings Inc
4,088$3.2M0.06%
617
PEPGPepGen Inc
679$3.1M0.06%
618
NKTXNkarta Inc
1,463$3.0M0.05%
619
FATEFate Therapeutics Inc
2,396$3.0M0.05%
620
PYXSPyxis Oncology Inc
1,334$3.0M0.05%
621
CLYMClimb Bio Inc
1,458$2.9M0.05%
622
BMEABiomea Fusion Inc
1,280$2.6M0.05%
623
MGNXMacroGenics Inc
1,303$2.2M0.04%
624
PLRXPliant Therapeutics Inc
1,264$1.9M0.03%
625
TCRXTScan Therapeutics Inc
1,020$1.9M0.03%
626
STROSutro Biopharma Inc
1,918$1.7M0.03%
627
ARTVArtiva Biotherapeutics Inc
510$1.5M0.03%
628
ACRVAcrivon Therapeutics Inc
650$1.2M0.02%
629
OKUROnKure Therapeutics Inc
271$745K0.01%
630
MRSNMersana Therapeutics Inc
94$729K0.01%
631
QTTBQ32 Bio Inc
227$449K0.01%
PreviousPage 7 of 7